Roflumilast 250 ug/1

Roflumilast 250 ug tablets are a pharmaceutical product used for managing respiratory conditions. This oral medication is designed to help improve breathing and reduce inflammation in the lungs.

Roflumilast is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the lungs, which can help improve breathing and reduce symptoms such as wheezing and shortness of breath. Roflumilast tablets are often prescribed for long-term management of COPD, helping patients maintain better respiratory function.

Common effects of Roflumilast may include headaches, diarrhea, nausea, and weight loss. Some users may also experience insomnia or dizziness. These effects can vary from person to person and are generally mild to moderate in nature.

Roflumilast should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with certain medical conditions or allergies should consult their doctor before using Roflumilast.

Roflumilast may interact with other medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of Roflumilast.